Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 14, 2022 Filed Jan 19, 2022 16:52 UTC |
Rajangam KanyaChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 76,800 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001209191-22-003756 · doc4.xml · derivative · entry 2 Rajangam Kanya · CIK 0001816676 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,800 Underlying: Common Stock · 76,800 shares Expires 2032-01-13 F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 16:52 UTC |
Rajangam KanyaChief Medical Officer
|
GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003756 · doc4.xml · nonDerivative · entry 1 Rajangam Kanya · CIK 0001816676 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,800 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 21:53 UTC |
HASTINGS PAUL JDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 251,100 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001209191-22-003759 · doc4.xml · derivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,100 Underlying: Common Stock · 251,100 shares Expires 2032-01-13 F3 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 21:53 UTC |
HASTINGS PAUL JDirector · Chief Executive Officer
|
GrantCommon Stock | 41,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003759 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,961 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: Includes 7,714 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 16:51 UTC |
Hager Alicia J.Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001209191-22-003755 · doc4.xml · derivative · entry 3 Hager Alicia J. · CIK 0001553354 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-01-13 F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 16:51 UTC |
Hager Alicia J.Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 76,800 | $0.00 Strike: $12.14 | $0.00 |
DisclosureSEC source: 0001209191-22-003755 · doc4.xml · derivative · entry 2 Hager Alicia J. · CIK 0001553354 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,800 Underlying: Common Stock · 76,800 shares Expires 2032-01-13 F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 16:51 UTC |
Hager Alicia J.Chief Legal Officer
|
GrantCommon Stock | 12,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003755 · doc4.xml · nonDerivative · entry 1 Hager Alicia J. · CIK 0001553354 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,800 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,037 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 9 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,176 Underlying: Common Stock · 2,037 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F6 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,358 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 8 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,784 Underlying: Common Stock · 1,358 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionStock Option (right to buy) · Derivative | 405 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 7 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,190 Underlying: Common Stock · 405 shares Expires 2029-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionStock Option (right to buy) · Derivative | 340 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 6 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,707 Underlying: Common Stock · 340 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
SaleCommon Stock | 4,140 | $15.64 | $64,749.60 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 5 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.26 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionCommon Stock | 2,037 | $3.89 | $7,923.93 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 4 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionCommon Stock | 1,358 | $3.89 | $5,282.62 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 3 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionCommon Stock | 405 | $4.77 | $1,931.85 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 2 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 17:02 UTC |
Brandenberger RalphSr. VP, Technical Operations
|
Exercise / conversionCommon Stock | 340 | $0.41 | $139.40 |
DisclosureSEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 1 Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:35 UTC |
HASTINGS PAUL JDirector · Chief Executive Officer
|
SaleCommon Stock | 223 | $26.53 | $5,916.19 |
DisclosureSEC source: 0000899243-21-038637 · doc4.xml · nonDerivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,061 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · balance_after: Includes 19,285 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 20:35 UTC |
HASTINGS PAUL JDirector · Chief Executive Officer
|
SaleCommon Stock | 8,277 | $27.20 | $225,134.40 |
DisclosureSEC source: 0000899243-21-038637 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,284 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.65 to $27.58, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,285 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,037 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 9 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,213 Underlying: Common Stock · 2,037 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,358 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 8 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,142 Underlying: Common Stock · 1,358 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 405 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 7 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,595 Underlying: Common Stock · 405 shares Expires 2029-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 340 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 6 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,047 Underlying: Common Stock · 340 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
SaleCommon Stock | 4,140 | $32.08 | $132,811.20 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 5 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionCommon Stock | 2,037 | $3.89 | $7,923.93 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 4 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionCommon Stock | 1,358 | $3.89 | $5,282.62 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 3 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionCommon Stock | 405 | $4.77 | $1,931.85 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 2 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:52 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionCommon Stock | 340 | $0.41 | $139.40 |
DisclosureSEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 1 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 17:17 UTC |
Rajangam KanyaChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0000899243-21-032196 · doc4.xml · derivative · entry 3 Rajangam Kanya · CIK 0001816676 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,054 Underlying: Common Stock · 10,000 shares Expires 2028-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 3, 2022. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 17:17 UTC |
Rajangam KanyaChief Medical Officer
|
SaleCommon Stock | 10,000 | $37.28 | $372,800.00 |
DisclosureSEC source: 0000899243-21-032196 · doc4.xml · nonDerivative · entry 2 Rajangam Kanya · CIK 0001816676 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: This transaction was executed in multiple trades at prices ranging from $37.02 to $37.63, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 17:17 UTC |
Rajangam KanyaChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.41 | $4,100.00 |
DisclosureSEC source: 0000899243-21-032196 · doc4.xml · nonDerivative · entry 1 Rajangam Kanya · CIK 0001816676 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 16:50 UTC |
Trager JamesChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-031622 · doc4.xml · derivative · entry 3 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,412 Underlying: Common Stock · 2,250 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · derivative.exercise_date: This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 16:50 UTC |
Trager JamesChief Scientific Officer
|
SaleCommon Stock | 3,600 | $31.53 | $113,508.00 |
DisclosureSEC source: 0000899243-21-031622 · doc4.xml · nonDerivative · entry 2 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,372 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 16:50 UTC |
Trager JamesChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,250 | $3.89 | $8,752.50 |
DisclosureSEC source: 0000899243-21-031622 · doc4.xml · nonDerivative · entry 1 Trager James · CIK 0001816549 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 17:11 UTC |
Mahmood NadirSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-027552 · doc4.xml · derivative · entry 3 Mahmood Nadir · CIK 0001816598 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,743 Underlying: Common Stock · 3,500 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 17:11 UTC |
Mahmood NadirSee Remarks
|
SaleCommon Stock | 6,500 | $31.71 | $206,115.00 |
DisclosureSEC source: 0000899243-21-027552 · doc4.xml · nonDerivative · entry 2 Mahmood Nadir · CIK 0001816598 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,288 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · balance_after: Includes 5,293 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 17:11 UTC |
Mahmood NadirSee Remarks
|
Exercise / conversionCommon Stock | 3,500 | $3.89 | $13,615.00 |
DisclosureSEC source: 0000899243-21-027552 · doc4.xml · nonDerivative · entry 1 Mahmood Nadir · CIK 0001816598 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · balance_after: Includes 5,293 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:05 UTC |
HASTINGS PAUL JDirector · Chief Executive Officer
|
SaleCommon Stock | 3,807 | $26.89 | $102,370.23 |
DisclosureSEC source: 0000899243-21-025505 · doc4.xml · nonDerivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,561 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: This transaction was executed in multiple trades at prices ranging from $26.74 to $27.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 30,856 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:05 UTC |
HASTINGS PAUL JDirector · Chief Executive Officer
|
SaleCommon Stock | 4,693 | $26.39 | $123,848.27 |
DisclosureSEC source: 0000899243-21-025505 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,368 F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.72 to $26.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 30,856 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 18:06 UTC |
Mahmood NadirSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,800 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-024468 · doc4.xml · derivative · entry 2 Mahmood Nadir · CIK 0001816598 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,522 Underlying: Common Stock · 1,800 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 18:06 UTC |
Mahmood NadirSee Remarks
|
Exercise / conversionCommon Stock | 1,800 | $3.89 | $7,002.00 |
DisclosureSEC source: 0000899243-21-024468 · doc4.xml · nonDerivative · entry 1 Mahmood Nadir · CIK 0001816598 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,822 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest. Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 10:23 UTC |
Azzam Fouad OscarDirector
|
GrantStock Option (right to buy) · Derivative | 16,511 | $0.00 Strike: $25.03 | $0.00 |
DisclosureSEC source: 0000899243-21-023793 · doc4.xml · derivative · entry 1 Azzam Fouad Oscar · CIK 0001816531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 Underlying: Common Stock · 16,511 shares Expires 2031-06-12 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 14:26 UTC |
Scheiner ZacharyDirector
|
GrantStock Option (right to buy) · Derivative | 16,511 | $0.00 Strike: $25.03 | $0.00 |
DisclosureSEC source: 0000899243-21-023799 · doc4.xml · derivative · entry 1 Scheiner Zachary · CIK 0001816523 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 Underlying: Common Stock · 16,511 shares Expires 2031-06-12 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 14:26 UTC |
PATTERSON LEONE DDirector
|
GrantStock Option (right to buy) · Derivative | 16,511 | $0.00 Strike: $25.03 | $0.00 |
DisclosureSEC source: 0000899243-21-023798 · doc4.xml · derivative · entry 1 PATTERSON LEONE D · CIK 0001233539 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 Underlying: Common Stock · 16,511 shares Expires 2031-06-12 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 14:25 UTC |
Shawver LauraDirector
|
GrantStock Option (right to buy) · Derivative | 16,511 | $0.00 Strike: $25.03 | $0.00 |
DisclosureSEC source: 0000899243-21-023797 · doc4.xml · derivative · entry 1 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 Underlying: Common Stock · 16,511 shares Expires 2031-06-12 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 14:29 UTC |
George SimeonDirector
|
GrantStock Option (right to buy) · Derivative | 16,511 | $0.00 Strike: $25.03 | $0.00 |
DisclosureSEC source: 0000899243-21-023803 · doc4.xml · derivative · entry 1 George Simeon · CIK 0001595117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 Underlying: Common Stock · 16,511 shares Expires 2031-06-12 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 14:29 UTC |
Dybbs MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 16,511 | $0.00 Strike: $25.03 | $0.00 |
DisclosureSEC source: 0000899243-21-023802 · doc4.xml · derivative · entry 1 Dybbs Michael · CIK 0001601264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 Underlying: Common Stock · 16,511 shares Expires 2031-06-12 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| June 13, 2021 Filed Jun 15, 2021 20:25 UTC |
Behbahani AliDirector
|
GrantStock Option (right to buy) · Derivative | 16,511 | $0.00 Strike: $25.03 | $0.00 |
DisclosureSEC source: 0001209191-21-040587 · doc4.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 Underlying: Common Stock · 16,511 shares Expires 2031-06-12 F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 14:29 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,037 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-021981 · doc4.xml · derivative · entry 9 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,250 Underlying: Common Stock · 2,037 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: The option is vested and exercisable as to 18,561 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 14:29 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,358 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0000899243-21-021981 · doc4.xml · derivative · entry 8 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 1,358 shares Expires 2029-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · derivative.exercise_date: The option is vested and exercisable as to 5,583 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 14:29 UTC |
Brandenberger RalphSee Remarks
|
Exercise / conversionStock Option (right to buy) · Derivative | 405 | $0.00 Strike: $4.77 | $0.00 |
DisclosureSEC source: 0000899243-21-021981 · doc4.xml · derivative · entry 7 Brandenberger Ralph · CIK 0001853197 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 405 shares Expires 2029-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · derivative.exercise_date: The option is vested and exercisable as to 5,721 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.